Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Hansoh Pharmaceutical Group Company Limited ( (HK:3692) ) is now available.
Hansoh Pharmaceutical Group Company Limited announced a final cash dividend of HKD 0.1353 per share for the financial year ending December 31, 2024. The dividend is subject to shareholders’ approval on June 20, 2025, and will be paid on July 25, 2025. This announcement reflects the company’s stable financial performance and commitment to returning value to its shareholders, potentially strengthening its market position and investor confidence.
More about Hansoh Pharmaceutical Group Company Limited
Hansoh Pharmaceutical Group Company Limited operates in the pharmaceutical industry, focusing on the development, manufacture, and sale of a wide range of pharmaceutical products. The company is known for its innovative drug development and has a significant market presence in China.
YTD Price Performance: 38.31%
Average Trading Volume: 10,617,561
Technical Sentiment Signal: Sell
Current Market Cap: HK$142.1B
For a thorough assessment of 3692 stock, go to TipRanks’ Stock Analysis page.